首页> 外国专利> COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER AND ADHD, AND METHODS FOR USING THE SAME

COMBINATION THERAPIES FOR TREATING BIPOLAR DISORDER AND ADHD, AND METHODS FOR USING THE SAME

机译:治疗双歧疾病和注意力缺陷多动障碍的组合疗法及其使用方法

摘要

The present invention relates to pharmaceutical combinations and compositions, and methods of using the same for treatment of attention deficit hyperactivity disorder (ADHD) and bipolar disorder (BD). The invention relates to combination therapies for the treatment of BD and for ADHD, and methods for treating BD and ADHD using such therapies. The present invention also relates to methods of determining an optimal combination drug treatment therapy for BD and for ADHD, methods of optimizing a combination drug treatment therapy for BD and for ADHD, methods of optimizing dosage of a drug in a combination drug treatment therapy for BD and for ADHD, as well as methods for monitoring the efficacy of a combination therapy for the treatment of BD and for ADHD. The present invention involves analyzing the membrane potential of cells isolated from a BD patient treated with the combination therapy and from an ADHD patient treated with the combination therapy, and calculating a membrane potential ratio therefrom.
机译:本发明涉及药物组合物和组合物,以及将其用于治疗注意力缺陷多动障碍(ADHD)和双相情感障碍(BD)的方法。本发明涉及用于治疗BD和ADHD的联合疗法,以及使用这种疗法治疗BD和ADHD的方法。本发明还涉及确定用于BD和ADHD的最佳组合药物治疗的方法,优化用于BD和ADHD的组合药物治疗的方法,在用于BD的组合药物治疗中的优化药物剂量的方法。以及用于ADHD的方法,以及用于监测联合治疗BD和ADHD疗效的方法。本发明涉及分析从用联合疗法治疗的BD患者和从用联合疗法治疗的ADHD患者分离的细胞的膜电位,并据此计算膜电位比。

著录项

  • 公开/公告号WO2019089319A1

    专利类型

  • 公开/公告日2019-05-09

    原文格式PDF

  • 申请/专利权人 PSYCHNOSTICS LLC;

    申请/专利号WO2018US57277

  • 发明设计人 THIRUVENGADAM ALAGU P.;

    申请日2018-10-24

  • 分类号C12Q1;C12Q1/02;

  • 国家 WO

  • 入库时间 2022-08-21 11:54:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号